SEEL Stock
Price Chart
SEEL Financial and Trading Overview
| stock price | 0.37 |
| Previous Close | 1.1 |
| Open | 1.12 |
| Bid | 0 x 4000 |
| Ask | 0 x 1200 |
| Day's Range | 1.05 - 1.17 |
| 52 Week Range | 0.58 - 1.52 |
| Volume | 532.77K |
| Avg. Volume | 465.5K |
| Market Cap | 127.9M |
| Beta (5Y Monthly) | 1.930755 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.25 |
SEEL Valuation Measures
| Enterprise Value | 136.71M |
| Trailing P/E | N/A |
| Forward P/E | -2.5609756 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 158.29399 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 169.198 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.930755 |
| 52-Week Change | 56.71% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.52 |
| 52 Week Low | 0.58 |
| 50-Day Moving Average | 0.86 |
| 200-Day Moving Average | 0.88 |
SEEL Share Statistics
| Avg. Volume (3 month) | 465.5K |
| Avg. Daily Volume (10-Days) | 692.67K |
| Shares Outstanding | 121.81M |
| Float | 118.38M |
| Short Ratio | 12.65 |
| % Held by Insiders | 2.81% |
| % Held by Institutions | 19.89% |
| Shares Short | 5.48M |
| Short % of Float | 4.62% |
| Short % of Shares Outstanding | 4.50% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -8148.26% |
| Gross Margin | 637.25% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -87.23% |
| Return on Equity (ttm) | -584.20% |
Income Statement
| Revenue (ttm) | 808K |
| Revenue Per Share (ttm) | 0.007 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -72964000 |
| Diluted EPS (ttm) | -0.68 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.06M |
| Total Cash Per Share (mrq) | 0.12 |
| Total Debt (mrq) | 16.78M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.602 |
| Book Value Per Share (mrq) | -0.17 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -54907000 |
| Levered Free Cash Flow (ttm) | -16162500 |
Profile of
| Country | United States |
| State | NY |
| City | New York |
| Address | 300 Park Avenue |
| ZIP | 10022 |
| Phone | 646 293 2100 |
| Website | https://seelostherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 16 |
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, a peptidic inhibitor to treat patients with PD; SLS-008 for the treatment of pediatric indications; SLS-004 for the treatment of PD; SLS-010, an H3 receptor antagonist; and SLS-012. The company was founded in 2016 and is headquartered in New York, New York.
Q&A For Stock
What is a current SEEL stock price?
SEEL stock price today per share is 0.37 .
How to purchase stock?
You can buy SEEL shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ?
The stock symbol or ticker of is SEEL.
Which industry does the company belong to?
The industry is Biotechnology.
How many shares does have in circulation?
The max supply of shares is 0.
What is Price to Earnings Ratio (PE Ratio)?
PE Ratio is 0.00000000 now.
What was earnings per share over the trailing 12 months (TTM)?
EPS is 0 over the trailing 12 months.
Which sector does the company belong to?
The sector is Healthcare.
SEEL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 18737.21 USD — |
-1
|
7.88B USD — | 18599.69 USD — | 18841.52 USD — | — - | 7.88B USD — |
| NASDAQ Capital Market Composite RCMP | 112.43 USD — |
+0.26
|
— — | 109.69 USD — | 112.55 USD — | — - | — — |
| Nasdaq Health Care IXHC | 932.02 USD — |
-0.03
|
— — | 920.46 USD — | 933.54 USD — | — - | — — |
- {{ link.label }} {{link}}